PLAYSTUDIOS INC (MYPS)

US72815G1085 - Common Stock

1.38  +0.01 (+0.73%)

After market: 1.35 -0.03 (-2.17%)

Fundamental Rating

4

Taking everything into account, MYPS scores 4 out of 10 in our fundamental rating. MYPS was compared to 72 industry peers in the Entertainment industry. No worries on liquidiy or solvency for MYPS as it has an excellent financial health rating, but there are worries on the profitability. MYPS does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

In the past year MYPS has reported negative net income.
MYPS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MYPS reported negative net income in multiple years.
Each year in the past 5 years MYPS had a positive operating cash flow.

1.2 Ratios

MYPS has a Return On Assets (-5.77%) which is in line with its industry peers.
With a Return On Equity value of -7.30%, MYPS perfoms like the industry average, outperforming 59.15% of the companies in the same industry.
Industry RankSector Rank
ROA -5.77%
ROE -7.3%
ROIC N/A
ROA(3y)-2.38%
ROA(5y)3.21%
ROE(3y)-3.03%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of MYPS (74.82%) is better than 90.14% of its industry peers.
In the last couple of years the Gross Margin of MYPS has grown nicely.
The Profit Margin and Operating Margin are not available for MYPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y2.64%

8

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYPS has more shares outstanding
MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MYPS has an Altman-Z score of 2.68. This is not the best score and indicates that MYPS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of MYPS (2.68) is better than 81.69% of its industry peers.
MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.68
ROIC/WACCN/A
WACC9.01%

2.3 Liquidity

MYPS has a Current Ratio of 4.14. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.14, MYPS belongs to the top of the industry, outperforming 90.14% of the companies in the same industry.
A Quick Ratio of 4.14 indicates that MYPS has no problem at all paying its short term obligations.
The Quick ratio of MYPS (4.14) is better than 90.14% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 4.14

3

3. Growth

3.1 Past

MYPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -366.67%.
Looking at the last year, MYPS shows a decrease in Revenue. The Revenue has decreased by -1.95% in the last year.
MYPS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.72% yearly.
EPS 1Y (TTM)-366.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-1.95%
Revenue growth 3Y4.83%
Revenue growth 5Y9.72%
Sales Q2Q%-6.69%

3.2 Future

MYPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.22% yearly.
Based on estimates for the next years, MYPS will show a small growth in Revenue. The Revenue will grow by 2.32% on average per year.
EPS Next Y62.99%
EPS Next 2Y42.5%
EPS Next 3Y27.22%
EPS Next 5YN/A
Revenue Next Year-6.33%
Revenue Next 2Y-1.84%
Revenue Next 3Y-0.33%
Revenue Next 5Y2.32%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYPS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 300.65, MYPS can be considered very expensive at the moment.
MYPS's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.28. MYPS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 300.65

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYPS is valued cheaper than 90.14% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MYPS is valued cheaply inside the industry as 88.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.69
EV/EBITDA 1.65

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MYPS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MYPS's earnings are expected to grow with 27.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.5%
EPS Next 3Y27.22%

0

5. Dividend

5.1 Amount

MYPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PLAYSTUDIOS INC

NASDAQ:MYPS (11/4/2024, 8:25:35 PM)

After market: 1.35 -0.03 (-2.17%)

1.38

+0.01 (+0.73%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap172.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 300.65
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.77%
ROE -7.3%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 74.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.14
Quick Ratio 4.14
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-366.67%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y62.99%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.95%
Revenue growth 3Y4.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y